SCSigne Bedsted Clemmensen

Signe Bedsted Clemmensen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Signe Bedsted Clemmensen has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians

    by Nanna Mørk, Julie A. Jensen, Paul Bastard, Lisbeth Aagaard Larsen, Bettina Bundgaard, Marianne Nygaard, Signe Bedsted Clemmensen, Chiaki Tao, Vibeke Sorensen Catts, Anne Puel, et al.

    While autoantibodies (auto-Abs) neutralizing type I interferons (IFN-I) are relatively rare before the age of 65 (6% in individuals above 80 years in the general population. To assess the prevalence of IFN-I auto-Abs at the extreme end of human lifespan, we performed a multinational study of centenarians from four geographically and ethnically distinct cohorts collected in Denmark (n = 258), Colombia (n = 99), Australia (n = 281), and Japan (n = 300), comprising 938 individuals. Across cohorts, 51/938 centenarians (5.4%) harbored auto-Abs neutralizing IFN-I, ranging from 3.3% (Japan) to 9.1% (Colombia). We found that the prevalence of IFN-I auto-Abs levels off in centenarians compared with individuals ≥80 years from the general population, demonstrating that neutralizing IFN-I auto-Abs are not incompatible with longevity, despite conferring a risk of life-threatening viral infections. Yet, the plateau of their prevalence in centenarians suggests that they may not be beneficial for reaching exceptional longevity and may negatively impact mortality.

  • Open Access

    Autoantibodies neutralizing type I interferons in older twin pairs: Low concordance

    by Signe Bedsted Clemmensen, Nanna Mørk, Julie A. Jensen, Lisbeth Aagaard Larsen, Bettina Bundgaard, Marianne Nygaard, Michelle Møhlenberg, Morten K. Skouboe, Adrian Gervais, Paul Bastard, et al.

    Autoantibodies (auto-Abs) neutralizing type I interferons (IFN-I) underlie various life-threatening viral infections, and the prevalence of these auto-Abs rises sharply between 65 and 70 years of age. We investigated the familial aggregation of neutralizing IFN-I auto-Abs by assessing concordance rates in Danish older twins, including 3,270 twins aged 65–96 years in a sample comprising 1,318 intact twin pairs (2,636 individuals) and 634 twins from broken twin pairs (634 individuals). Neutralizing IFN-I auto-Abs were detected in 1.5% (50/3,270) of all twins tested, including 1.4% (37/2,636) in twins from intact pairs and 2.1% (13/634) in twins from broken pairs. A total of 50 twins had neutralizing IFN-I auto-Abs, including one concordant monozygotic pair and 35 discordant pairs, yielding a low overall concordance rate. A slight, but nonsignificant, increase in mortality was associated with harboring neutralizing IFN-I auto-Abs. Collectively, these findings do not reveal any familial aggregation of IFN-I auto-Abs, arguing against a strong germline genetic etiology of IFN-I auto-Abs in older adults.

  • Open Access

    Genetic and Shared Environmental Influences on Cancer Risk and Cross-Cancer Associations in Nordic Twins

    by Jennifer R. Harris, Signe Bedsted Clemmensen, Hans-Olov Adami, Lorelei A. Mucci, Jaakko Kaprio, Jacob von Bornemann Hjelmborg

    The relative contributions of genetic and shared environmental influences to cancer risk and cross-cancer associations remain poorly understood. We analyzed data from 222,530 same-sex twins from Denmark, Finland, Norway, and Sweden in the Nordic Twin Study of Cancer, including 43,060 incident cancers over a median follow-up of 41.6 years. Using a target trial framework, biometric modeling, and competing-risk adjustment, we estimated familial risk, heritability, and shared environmental contributions across 35 cancer sites. Lifetime cancer risk was 36.5%, increasing to 51.4% in monozygotic (MZ) twins and 45.3% in dizygotic (DZ) twins with an affected co-twin. Overall cancer risk was explained by heritable (28%) and shared environmental (40%) influences. Heritability was highest for prostate (42%), non-melanoma skin (24%), and breast (18%) cancers. Cross-cancer analyses revealed extensive overlap in the genetic and shared environmental factors across sites, consistent with widespread pleiotropy and shared environmental susceptibility. Prostate cancer exhibited the strongest genetic overlap with rectum/anus (12%) and kidney (11%) cancers, whereas co-shared environmental influences were most pronounced for breast-lung (11%), prostate-bladder (11%), and prostate-lung (12%) cancers. These findings show pervasive genetic overlap across cancers at different sites and emphasize the importance of incorporating familial shared environmental exposures into cancer risk prediction and prevention strategies.

  • Open Access

    Tattooing is Mainly Cultural: A Representative Twin Study of Tattooing Determinants

    by Signe B. Clemmensen, Jonas Mengel-From, Jaakko Kaprio, Jennifer R. Harris, Henrik Frederiksen, Jacob von Bornemann Hjelmborg

    Tattooing has become increasingly common in recent decades, yet little is known regarding factors that influence tattoo behavior. Sources of influence will be important, for instance in aiding studies of long-term health effects. From the population-based Danish Twin Tattoo Cohort established in 2021, the study included 9,173 randomly selected twins born 1920–2004. Among these were 4,790 (52%) responders to a questionnaire on tattooing and lifestyle factors. There were 55% females, 22% were monozygotic twins, and the median age was 51 years. Shared influence of tattooing over time was assessed by comparing monozygotic and dizygotic twin pairs. Responders were population representative on sex, age, and lifestyle factors. The cumulative incidence of being tattooed before age 25 years increased markedly from 6% (95% CI: 4–7%) for males and 0% (0–1%) for females born in 1925–1960 to 30% (25–35%) for males and 41% (37–46%) for females born in 1981–2004. Tattooing was over twice as common among ever smokers compared to never smokers born in 1981–2004 (average smoking effect at age 25 years: 36% (29–43%)). The likelihood of a twin getting tattooed if the co-twin is tattooed, was 2.0 (1.4–2.6) and 1.8 (1.5–2.2) times higher, for monozygotic and dizygotic twins, respectively. The findings indicate that variation in the likelihood of becoming tattooed is primarily explained by shared environmental factors 65% (35–95%), and that genetic influences explained little of this variation. This study demonstrates that strong environmental exposures shared by twin siblings irrespective of degree of genetic relatedness drive the choice for getting tattooed. We conclude that tattooing is a cultural group clustering phenomenon that goes beyond genetically oriented behavioral characteristics.


  • Top Cited Papers
    Open Access

    Tattoo ink exposure is associated with lymphoma and skin cancers – a Danish study of twins

    by Signe Bedsted Clemmensen, Jonas Mengel-From, Jaakko Kaprio, Henrik Frederiksen, Jacob von Bornemann Hjelmborg

    Background: We aim to study the potential association between tattoo ink exposure and development of certain types of cancers in the recently established Danish Twin Tattoo Cohort. Tattoo ink is known to transfer from skin to blood and accumulate in regional lymph nodes. We are concerned that tattoo ink induces inflammation at the deposit site, leading to chronic inflammation and increasing risk of abnormal cell proliferation, especially skin cancer and lymphoma. Methods: We conducted two designs of twin studies to improve confounder control: A cohort study of 2,367 randomly selected twins and a case-control study of 316 twins born in the period 1960–1996. Cancer diagnoses (ICD-10) were retrieved from the Danish Cancer Registry and tattoo ink exposure from the Danish Twin Tattoo survey from 2021. The analysis addressed effects of time-varying exposure. Results: In the case-control study, individual-level analysis resulted in a hazard of skin cancer (of any type except basal cell carcinoma) that was 1.62 times higher among tattooed individuals (95% CI: 1.08–2.41). Twin-matched analysis of 14 twin pairs discordant for tattoo ink exposure and skin cancer showed HR = 1.33 (95% CI: 0.46–3.84). For skin cancer and lymphoma, increased hazards were found for tattoos larger than the palm of a hand: HR = 2.37 (95% CI: 1.11–5.06) and HR = 2.73 (95% CI: 1.33–5.60), respectively. In the cohort study design, individual-level analysis resulted in a hazard ratio of 3.91 (95% CI: 1.42–10.8) for skin cancer and 2.83 (95% CI: 1.30–6.16) for basal cell carcinoma. Conclusion: In conclusion, our study suggests an increased hazard of lymphoma and skin cancers among tattooed individuals, demonstrated through two designs: a twin cohort and a case-cotwin study. We are concerned that tattoo ink interacting with surrounding cells may have severe consequences. Studies that pinpoint the etiological pathway of tattoo ink induced carcinogenesis are recommended to benefit public health.


  • Open Access

    Novel epigenetic biomarkers for hematopoietic cancer found in twins

    by Signe B. Clemmensen, Henrik Frederiksen, Jonas Mengel-From, Aino Heikkinen, Jaakko Kaprio, Jacob Vb Hjelmborg

    Background and purpose: This article aims to identify epigenetic markers and detect early development of hematopoietic malignancies through an epigenome wide association study of DNA methylation data. Materials and methods: This register-based study includes 1,085 Danish twins with 31 hematopoietic malignancies and methylation levels from 450,154 5’-C-phospate-G-3’ (CpG) sites. Associations between methylation levels and incidence of hematopoietic malignancy is studied through time-to-event regression. The matched case-cotwin design, where one twin has a malignancy and the cotwin does not, is applied to enhance control for unmeasured shared confounding and false discoveries. Predictive performance is validated in the independent Older Finnish Twin Cohort. Results and interpretation: We identified 67 epigenetic markers for hematopoietic malignancies of which 12 are linked to genes associated with hematologic malignancies. For some markers, we discovered a 2–3-fold relative risk difference for high versus low methylation. The identification of these 67 sites enabled the formation of a predictor demonstrating a cross-validated time-varying area under the curve (AUC) of 92% 3 years after individual blood sampling and persistent performance above 70% up to 6 years after blood sampling. This predictive performance was to a large extent recovered in the validation sample showing an overall Harrell’s C of 73%. In conclusion, from a large population representative twin study on hematopoietic cancers, novel epigenetic markers were identified that may prove useful for early diagnosis.

  • Open Access

    Tattoo ink exposure is associated with lymphoma and skin cancers – a Danish study of twins

    by Signe B. Clemmensen, Jonas Mengel-From, Jaakko Kaprio, Henrik Frederiksen, Jacob Vb. Hjelmborg

    We aim to study the possible association between tattoo ink exposure and development of certain cancers in the recently established Danish Twin Tattoo Cohort. Tattoo ink is known to transfer from skin to blood stream and accumulate in regional lymph nodes. We are concerned that tattoo ink induce inflammation at deposit site that may eventually become chronic and increase risk of abnormal cell proliferation, especially skin cancer and lymphoma. We conducted two designs of study in twins in order to improve confounder control: A cohort study of 2,367 randomly selected twins and a case-control study of 316 twins born in the period 1960-1996. Cancer diagnoses (ICD-10) were retrieved from the Danish Cancer Registry and tattoo ink exposure from the Danish Twin Tattoo survey from 2021. The analysis addressed effects of time-varying exposure. In the case-control study, individual level analysis resulted in a hazard of skin cancer (of any type except basal cell carcinoma) that was 1.62 times higher among tattooed (95% CI: 1.08-2.41). Twin-matched analysis of 14 twin pairs discordant for tattoo ink exposure and skin cancer show HR=1.33 (95% CI: 0.46-3.84). For skin cancer and lymphoma, increased hazards were found for tattoos larger than the palm of a hand: HR=2.37 (95% CI: 1.11-5.06) and HR=2.73 (95% CI: 1.33-5.60), respectively. In the cohort study design, individual level analysis resulted in a hazard ratio of 3.91 (95% CI: 1.42-10.8) for skin cancer and 2.83 (95% CI: 1.30-6.16) for basal cell carcinoma. In conclusion, we are very concerned that tattoo ink interacting with surrounding cells may have severe consequences. Further studies are needed beneficial to public health – the sooner the better.


  • Open Access

    Identifying genetic variants regulating MGMT gene expression - A study in monozygotic Danish twins

    by Afsaneh Mohammadnejad, Mette Soerensen, Jonas Mengel-From, Marianne Nygaard, Maria Timofeeva, Liang He, Signe Bedsted Clemmensen, Ulrich Halekoh, Rikke Hedegaard Dahlrot, Qihua Tan, et al.

  • Evidence of gene–gene interaction in hidradenitis suppurativa: a nationwide registry study of Danish twins

    by R. Kjærsgaard Andersen, S.B. Clemmensen, L.A. Larsen, J.V.B. Hjelmborg, N. Ødum, G.B.E. Jemec, K. Christensen

    Summary: Background Hidradenitis suppurativa (HS) is a recurrent inflammatory skin disease that, apart from rare causative loss-of-function mutations, has a widely unknown genetic aetiology. Objectives To estimate the relative importance of genetic and environmental factors underlying susceptibility to HS. Methods Via the Danish Twin Registry and the Danish National Patient Registry we pulled together information on zygosity with that of HS status. Cases of HS were identified by the International Classification of Diseases (ICD)-8 (705·91) and ICD-10 (L73·2). Heritability was assessed by the classic biometric model and the possibility of gene–gene interaction via the multilocus modelling approach. Results Among 100 044 registered twins, we found 170 twins (from 163 pairs) diagnosed with HS. The seven concordant pairs were all monozygotic. Monozygotic twins had a case-wise concordance rate of 28% [95% confidence interval (CI) 7–49], corresponding to a familial risk of 73 (95% CI 13–133) times that of the background population. The biometrical modelling suggested a heritability of 0·80 (95% CI 0·67–0·93), and the multilocus index estimate was 230 (95% CI 60–400). This is highly indicative of gene–gene interactions, with the possibility of up to six interacting loci. Conclusions This twin study was substantially larger and employed a more valid phenotype than previous studies. Genetics account for the majority of HS susceptibility, and HS is most likely caused by gene–gene interactions rather than monogenetic mutations or solely additive genetic factors. New approaches aimed at assessing potential interactions at a single-nucleotide polymorphism (SNP)–SNP level should be implemented in future HS genome-wide association studies.


  • Open Access

    Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer

    by Signe B. Clemmensen, Jennifer R. Harris, Jonas Mengel-From, Wagner H. Bonat, Henrik Frederiksen, Jaakko Kaprio, Jacob V. B. Hjelmborg

    We aimed to explore the genetic and environmental contributions to variation in the risk of hematologic malignancies and characterize familial dependence within and across hematologic malignancies. The study base included 316,397 individual twins from the Nordic Twin Study of Cancer with a median of 41 years of follow-up: 88,618 (28%) of the twins were monozygotic, and 3459 hematologic malignancies were reported. We estimated the cumulative incidence by age, familial risk, and genetic and environmental variance components of hematologic malignancies accounting for competing risk of death. The lifetime risk of any hematologic malignancy was 2.5% (95% CI 2.4–2.6%), as in the background population. This risk was elevated to 4.5% (95% CI 3.1–6.5%) conditional on hematologic malignancy in a dizygotic co-twin and was even greater at 7.6% (95% CI 4.8–11.8%) if a monozygotic co-twin had a hematologic malignancy. Heritability of the liability to develop any hematologic malignancy was 24% (95% CI 14–33%). This estimate decreased across age, from approximately 55% at age 40 to about 20–25% after age 55, when it seems to stabilize. In this largest ever studied twin cohort with the longest follow-up, we found evidence for familial risk of hematologic malignancies. The discovery of decreasing familial predisposition with increasing age underscores the importance of cancer surveillance in families with hematological malignancies.